News Focus
News Focus
icon url

JRoon71

10/23/24 10:03 AM

#429814 RE: AMRNEPA #429813

Keep in mind, that $5-7M includes some revenue that we already were seeing from Canada and UK last quarter. I believe we were just under $4M between the two last quarter ($3.5M in UK and $200K from Canada).

As far as PBM negotiations, I have no idea. I don't know if Amarin can approach them with a new offer, or if the PBM's just make decisions unilaterally.

EDIT: Licensing revenue from Canada was actually closer to $600-700K I think. Can't find solid number in 10Q, so trying to extrapolate from HLS revenues, and applying licensing fee %. The $200K I believe was from all other partners around the world.
icon url

Number sleven

10/23/24 10:16 AM

#429815 RE: AMRNEPA #429813

Triple,
https://www.techtarget.com/healthcarepayers/feature/How-Payers-and-Pharmacy-Benefit-Managers-Work-Together-to-Lower-Costs
Pharmacy benefit managers negotiate with manufacturers on behalf of their clients. I don't know how often this process takes place.
Sleven,